ArticleCurrent protocols2022

Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.

Jean Ann Maguire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.